Skip to main content
. 2016 Jul 15;11(7):e0158205. doi: 10.1371/journal.pone.0158205

Fig 2. Transgenic hAPPSwe/PS1ΔE9 mice.

Fig 2

(A) Absolute body weight development; (B) Relative body weight development (% of day 0). *p<0.05 vs. individual experimental groups of hAPPLon/PS1A246E mice; (C) Plasma liraglutide concentrations determined after 1, 3 and 5 months of daily dosing (pre-dosing vs. 3h post-dosing). *p<0.05, ***p<0.001 vs. pre-dosing; (D) Survival rate of C57Bl6 wild-type controls and hAPPSwe/PS1ΔE9 mice.